En Carta Diagnostics

📍 Paris, France👥 12 employees💰 Last funded May 2026
Biotechnology Research🌐 encarta.bio
Website LinkedIn
Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.
5
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
4
Germany
1
Investor activity2024–2026 · investors recorded per year
202422025120262
Recent (last 2y)Earlier
Frequently asked questions
Who invested in En Carta Diagnostics?
En Carta Diagnostics has 5 investors on record on gritt.io.
When did En Carta Diagnostics last raise funding?
The most recent investment in En Carta Diagnostics recorded on gritt.io was in May 2026.
What industry is En Carta Diagnostics in?
En Carta Diagnostics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is En Carta Diagnostics based?
En Carta Diagnostics is headquartered in Paris, France.